García, Margarita <br/><br/>
A Phase 1 Trial of Oncolytic Adenovirus ICOVIR-5 Administered Intravenously to Cutaneous and Uveal Melanoma Patients.  [electronic resource] 

 -  Human gene therapy  03 2019 
 - 352-364 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1557-7422 
<br/><br/><label>Standard No.: </label>10.1089/hum.2018.107  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenoviridae--genetics<br/>Administration, Intravenous<br/>Animals<br/>Biopsy<br/>Cytokines--metabolism<br/>Gene Order<br/>Genetic Therapy--adverse effects<br/>Genetic Vectors--administration & dosage<br/>Humans<br/>Melanoma--diagnosis<br/>Mice<br/>Oncolytic Virotherapy--adverse effects<br/>Oncolytic Viruses--genetics<br/>Tissue Distribution<br/>Treatment Outcome<br/>Virus Replication